Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review.
about
Monoclonal antibody therapy and renal transplantation: focus on adverse effectsFirst-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejectionTargeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificityRabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival.B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.Infectious complications associated with monoclonal antibodies and related small moleculesEmerging drugs for the treatment of transplant rejection.Induction therapy in renal transplant recipients: a review.The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects.Lymphocyte-depleting induction therapy lowers the risk of acute rejection in African American pediatric kidney transplant recipients.Alemtuzumab versus antithymocyte globulin induction therapies in kidney transplantation patients: A systematic review and meta-analysis of randomized controlled trials.Interleukin-2 receptor antagonist compared with antithymocyte globulin induction therapy in kidney transplantation from donors after cardiac death.Comparison of the Effect of Alemtuzumab versus Standard Immune Induction on Early Kidney Allograft Function in Shiraz Transplant Center.Cyclosporine versus tacrolimus in immunosuppressive maintenance regimens in renal transplants in Brazil: survival analysis from 2000 to 2004.
P2860
Q26826880-30AA055E-9B50-4FF3-B1A2-84EF013B3D58Q30389408-0B5DED1F-CC5D-43EF-9FDD-0580442B5F46Q33415472-8F575806-C884-4C8F-8C57-BF69D75D408FQ36335918-2D6A9C26-EC38-4C6D-B27A-D7FD885ABF6BQ36429791-54BA8008-17E6-4742-8ABD-2CF5A71939A3Q37156636-DC998B41-3926-4B6F-9E7D-D8C93DFE1934Q37960177-9D55452B-A911-4F7D-9924-7AFE236EF505Q38258154-78673CA7-99E9-46DE-BEC6-60CD24C5D129Q38424224-D38E8366-6401-4169-B13C-A992FE6C05A3Q38995172-C216DFB3-3F96-4811-B866-D51D34F805B2Q39325233-8078726A-FE10-4142-ACA1-EDF6BA96073CQ39430754-8076F344-D36C-4AA3-A502-1961534AC001Q41107298-637415BC-C139-46CC-BBE5-DDA52BBB7C12Q42252690-D61444FC-D6FA-422B-AA83-46C03C45F373Q43222628-6CC37746-C6FA-4E78-9E66-3E3A65F29FF4
P2860
Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antibody induction therapy in ...... egimens: a comparative review.
@ast
Antibody induction therapy in ...... egimens: a comparative review.
@en
type
label
Antibody induction therapy in ...... egimens: a comparative review.
@ast
Antibody induction therapy in ...... egimens: a comparative review.
@en
prefLabel
Antibody induction therapy in ...... egimens: a comparative review.
@ast
Antibody induction therapy in ...... egimens: a comparative review.
@en
P1433
P1476
Antibody induction therapy in ...... egimens: a comparative review.
@en
P2093
Björn Nashan
P356
10.2165/00063030-200519010-00005
P577
2005-01-01T00:00:00Z
P5875
P6179
1052756926